https://functional.news/article/polyrizon-s-nasarix-nasal-barrier-advances-human-residency-study Functional News en 2026-06-15T12:05:00.000Z Polyrizon's NASARIX™ Nasal Barrier Advances Human Residency Study https://functional.news/article/protein-quality-drives-sandwich-satisfaction-survey-data-shows Functional News en 2026-06-15T12:00:00.000Z Protein Quality Drives Sandwich Satisfaction, Survey Data Shows https://functional.news/article/hillshire-reserve-relaunches-deli-meat-line-with-hardwood-smoke-positioning Functional News en 2026-06-15T12:00:00.000Z Hillshire Reserve Relaunches Deli Meat Line With Hardwood-Smoke Positioning https://functional.news/article/editor-s-note-off-topic-release-flagged-for-review Functional News en 2026-06-15T12:00:00.000Z Editor's Note: Off-Topic Release Flagged for Review https://functional.news/article/off-topic-submission-no-functional-food-content-detected-b3faac Functional News en 2026-06-15T12:00:00.000Z Off-Topic Submission: No Functional Food Content Detected https://functional.news/article/press-release-outside-functional-foods-scope-no-coverage Functional News en 2026-06-15T12:00:00.000Z Press Release Outside Functional Foods Scope: No Coverage https://functional.news/article/grifols-launches-fda-approved-fibrinogen-concentrate-fesilty-in-u-s Functional News en 2026-06-15T12:00:00.000Z Grifols Launches FDA-Approved Fibrinogen Concentrate FESILTY in U.S. https://functional.news/article/car-t-cell-therapy-lb2501-shows-early-clinical-signal-in-b-cell-lymphoma Functional News en 2026-06-15T12:00:00.000Z CAR-T Cell Therapy LB2501 Shows Early Clinical Signal in B-Cell Lymphoma https://functional.news/article/humacyte-bioengineered-vessel-posts-phase-3-win-in-dialysis-access Functional News en 2026-06-15T12:00:00.000Z Humacyte Bioengineered Vessel Posts Phase 3 Win in Dialysis Access https://functional.news/article/anti-tl1a-therapy-spy002-hits-primary-endpoint-in-uc-induction-trial Functional News en 2026-06-15T12:00:00.000Z Anti-TL1A Therapy SPY002 Hits Primary Endpoint in UC Induction Trial https://functional.news/article/off-topic-submission-no-functional-ingredient-or-nutraceutical-news-found Functional News en 2026-06-15T12:00:00.000Z Off-Topic Submission: No Functional Ingredient or Nutraceutical News Found https://functional.news/article/vaxart-oral-vaccine-platform-heads-to-bio-2026-showcase Functional News en 2026-06-15T12:00:00.000Z Vaxart Oral Vaccine Platform Heads to BIO 2026 Showcase https://functional.news/article/editor-s-note-this-release-falls-outside-functional-news-coverage-2d6336 Functional News en 2026-06-15T11:30:00.000Z Editor's Note: This Release Falls Outside Functional News Coverage https://functional.news/article/dyadic-c1-platform-gains-traction-in-nutraceutical-biomanufacturing Functional News en 2026-06-15T11:25:00.000Z Dyadic C1 Platform Gains Traction in Nutraceutical Biomanufacturing https://functional.news/article/pasithea-therapeutics-to-exhibit-at-2026-nf-conference Functional News en 2026-06-15T11:02:00.000Z Pasithea Therapeutics to Exhibit at 2026 NF Conference https://functional.news/article/elicio-therapeutics-amplify-7p-phase-2-data-mkras-cancer-vaccine-update Functional News en 2026-06-15T11:00:00.000Z Elicio Therapeutics AMPLIFY-7P Phase 2 Data: mKRAS Cancer Vaccine Update https://functional.news/article/lexeo-lx2006-gene-therapy-trial-targets-cardiac-endpoint-in-friedreich-ataxia Functional News en 2026-06-15T11:00:00.000Z Lexeo LX2006 Gene Therapy Trial Targets Cardiac Endpoint in Friedreich Ataxia https://functional.news/article/pharvaris-hae-drug-data-presented-at-eaaci-2026 Functional News en 2026-06-15T10:50:00.000Z Pharvaris HAE Drug Data Presented at EAACI 2026 https://functional.news/article/context-therapeutics-reports-29-response-rate-in-proc-phase-1-trial Functional News en 2026-06-15T10:30:00.000Z Context Therapeutics Reports 29% Response Rate in PROC Phase 1 Trial https://functional.news/article/ena-respiratory-wins-uspto-patents-for-tlr2-innate-immune-modulators Functional News en 2026-06-15T08:00:00.000Z ENA Respiratory Wins USPTO Patents for TLR2 Innate Immune Modulators https://functional.news/article/editor-s-note-this-release-falls-outside-functional-news-coverage-d66d62 Functional News en 2026-06-15T07:06:00.000Z Editor's Note: This Release Falls Outside Functional News Coverage https://functional.news/article/ai-in-radiology-gains-clinical-traction-at-hlth-europe-2026 Functional News en 2026-06-15T07:06:00.000Z AI in Radiology Gains Clinical Traction at HLTH Europe 2026 https://functional.news/article/ai-radiology-model-debuts-at-hlth-europe-2026 Functional News en 2026-06-15T07:06:00.000Z AI Radiology Model Debuts at HLTH Europe 2026 https://functional.news/article/mhra-clears-needle-free-epinephrine-device-for-pediatric-anaphylaxis Functional News en 2026-06-15T07:00:00.000Z MHRA Clears Needle-Free Epinephrine Device for Pediatric Anaphylaxis https://functional.news/article/enterome-s-oncomimics-eo2463-drives-cd8-t-cell-response-in-phase-1-2-lymphoma-st Functional News en 2026-06-15T06:30:00.000Z Enterome's OncoMimics™ EO2463 Drives CD8 T Cell Response in Phase 1/2 Lymphoma Study https://functional.news/article/orelabrutinib-data-at-eha-2026-what-nutraceutical-formulators-should-know Functional News en 2026-06-15T05:17:00.000Z Orelabrutinib Data at EHA 2026: What Nutraceutical Formulators Should Know https://functional.news/article/ascentage-pharma-posts-17-clinical-updates-at-eha2026 Functional News en 2026-06-14T23:30:00.000Z Ascentage Pharma Posts 17 Clinical Updates at EHA2026 https://functional.news/article/barzolvolimab-phase-2-data-show-durable-csu-remission-off-treatment Functional News en 2026-06-14T14:21:00.000Z Barzolvolimab Phase 2 Data Show Durable CSU Remission Off-Treatment https://functional.news/article/lorundrostat-linked-to-heart-failure-biomarker-reductions-in-proteomic-analysis Functional News en 2026-06-14T14:00:00.000Z Lorundrostat Linked to Heart Failure Biomarker Reductions in Proteomic Analysis https://functional.news/article/verekitug-phase-2-data-show-80-responder-rate-in-nasal-polyp-trial Functional News en 2026-06-14T14:00:00.000Z Verekitug Phase 2 Data Show 80% Responder Rate in Nasal Polyp Trial https://functional.news/article/world-blood-donor-day-industry-backs-donation-awareness-push Functional News en 2026-06-14T12:54:00.000Z World Blood Donor Day: Industry Backs Donation Awareness Push https://functional.news/article/globenewswire-health-files-mislabeled-release-to-functional-news Functional News en 2026-06-14T07:01:00.000Z GlobeNewswire Health Files Mislabeled Release to Functional News https://functional.news/article/off-topic-submission-no-functional-food-content-found Functional News en 2026-06-14T07:01:00.000Z Off-Topic Submission: No Functional Food Content Found https://functional.news/article/off-topic-submission-no-functional-ingredient-or-nutraceutical-found Functional News en 2026-06-14T07:01:00.000Z Off-Topic Submission: No Functional Ingredient or Nutraceutical Found https://functional.news/article/editor-s-note-this-release-falls-outside-functional-news-coverage-bc7172 Functional News en 2026-06-13T13:57:00.000Z Editor's Note: This Release Falls Outside Functional News Coverage https://functional.news/article/press-release-outside-functional-foods-scope-not-published-e3d789 Functional News en 2026-06-13T13:57:00.000Z Press Release Outside Functional Foods Scope — Not Published https://functional.news/article/off-topic-submission-no-functional-ingredient-news-to-report-69b5b6 Functional News en 2026-06-13T13:57:00.000Z Off-Topic Submission: No Functional Ingredient News to Report https://functional.news/article/mitapivat-phase-3-data-highlights-anti-hemolytic-mechanism-in-scd Functional News en 2026-06-13T13:00:00.000Z Mitapivat Phase 3 Data Highlights Anti-Hemolytic Mechanism in SCD